Management of Rheumatoid Arthritis in the Janus Kinase (JAK) Inhibitors Era

in mrmed •  11 months ago 

Countless people globally endure the challenges of rheumatoid arthritis, a persistent inflammatory condition leading to pain, swelling, and joint issues. A significant shift in rheumatology occurred with the introduction of Janus Kinase (JAK) inhibitors, bringing about transformative changes. Rheumatoid arthritis is an auto-immune disorder that causes chronic inflammation affecting many joints, including hands and feet.

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!